Lexeo Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lexeo Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2022 to Q3 2024.
  • Lexeo Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 33.1M shares, a 1932% increase year-over-year.
  • Lexeo Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5.35M shares, a 228% increase from 2022.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 33.1M +31.4M +1932% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 33M +31.4M +1938% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 28M +26.4M +1637% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 5.35M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 1.63M -16.4K -1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 1.62M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 1.61M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 1.64M Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.